- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 16/10 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus de virus à ARN
Détention brevets de la classe C07K 16/10
Brevets de cette classe: 5048
Historique des publications depuis 10 ans
|
235
|
268
|
276
|
289
|
431
|
541
|
521
|
469
|
302
|
105
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
142 |
| Vanderbilt University | 2030 |
78 |
| The Rockefeller University | 582 |
75 |
| The Scripps Research Institute | 1344 |
75 |
| Humabs Biomed SA | 120 |
74 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
73 |
| Duke University | 3186 |
60 |
| California Institute of Technology | 4037 |
47 |
| VIR Biotechnology, Inc. | 152 |
47 |
| The Wistar Institute of Anatomy and Biology | 487 |
46 |
| Dana-Farber Cancer Institute, Inc. | 2669 |
40 |
| The Trustees of Columbia University in the City of New York | 3649 |
34 |
| The Trustees of the University of Pennsylvania | 4432 |
34 |
| Academia Sinica | 959 |
34 |
| International AIDS Vaccine Initiative | 92 |
34 |
| Institut Pasteur | 776 |
32 |
| The Regents of the University of California | 20842 |
29 |
| Visterra, Inc. | 123 |
29 |
| Massachusetts Institute of Technology | 10285 |
28 |
| The University of North Carolina at Chapel Hill | 2116 |
27 |
| Autres propriétaires | 4010 |